PSU vaccine maker IIL to invest Rs 700 crore on new facility in Hyderabad

The proposed facility will be making Foot and Mouth disease (FMD) and other emerging diseases. The facility will create total employment for around 750 people. The facility is intended to be a state-of-art fully integrated biosafety level 3 (BSL-3) for drug substance (DS) production and respective fill-finish.

from Latest Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/f4rmCWx
https://ift.tt/ZUo5t6j

Post a Comment

أحدث أقدم